RichardSBurnsMD

PubMed

• 31 citations
  Impaired self-awareness of motor deficits in Parkinson's disease: association with motor asymmetry and motor phenotypes.
  Franziska Maier, George P. Prigatano, Elke Kalbe, Michael T. Barbe, Carsten Eggers, Catharine J. Lewis, Richard S. Burns, Jeannine Morrone-Strupinsky, Guillermo Moguel...> ;Movement Disorders. 2012 Sep 15
• 33 citations
  A U.S. survey of patients with Parkinson's disease: Satisfaction with medical care and support groups†
  E. Ray Dorsey, Tiffini S. Voss, David Shprecher, Lisa M. Deuel, Christopher A. Beck, Irenita Gardiner, Margaret A. Coles, Richard S. Burns, Frederick J. Marshall, Kevi...> ;Movement Disorders. 2010 Oct 15
• 4 citations
  The calcium-modulated structures of calmodulin and S100b proteins are useful to monitor hydrogen/deuterium exchange efficiency using matrix-assisted laser desorption i...
  Peter L Pingerelli, Victor V. Ozols, Haroon Saleem, Carly R Anderson, Richard S Burns> ;European Journal of Mass Spectrometry. 2009 Sep 25
• 170 citations
  A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease
  Karl Kieburtz, Bernard Ravina, Wendy R. Galpern, Barbara C. Tilley, Kathleen M. Shannon, Caroline M. Tanner, G. Frederick Wooten, Robert W. Hamill, Jacob I. Sage, Emil...> ;Neurology. 2007 Jan 2
• 34 citations
  Biomechanic characteristics of patients with spastic and dystonic hypertonia in cerebral palsy.
  Maria K. Lebiedowska, Deborah Gaebler-Spira, Richard S Burns, John R. Fisk> ;Archives of Physical Medicine and Rehabilitation. 2004 Jun 1
• Long-term exercise and its effect on balance in older, osteoarthritic adults: results from the Fitness, Arthritis, and Seniors Trial (FAST).
  Messier SP, Royer TD, Craven TE, O'Toole ML, Burns R, Ettinger WH> ;J Am Geriatr Soc. 2000-02-01
• Interdisciplinary geriatric primary care evaluation and management: two-year outcomes.
  Burns R, Nichols LO, Martindale-Adams J, Graney MJ> ;J Am Geriatr Soc. 2000-01-01
• Clathrin plays a novel role in the regulation of cell polarity, pseudopod formation, uropod stability and motility in Dictyostelium.
  Wessels D, Reynolds J, Johnson O, Voss E, Burns R, Daniels K, Garrard E, O'Halloran TJ, Soll DR> ;J. Cell. Sci.. 2000-01-01
• 115 citations
  Clinical presentation and pharmacological therapy in corticobasal degeneration
  Katie Kompoliti, Christopher G. Goetz, B. F. Boeve, Demetrius M. Maraganore, J. E. Ahlskog, C. D. Marsden, Kailash P. Bhatia, Paul Greene, Serge Przedborski, E. C. Sea...> ;Archives of Neurology. 1998 Jul 1
• Effect of tolcapone on plasma levodopa concentrations after coadministration with levodopa/carbidopa to healthy volunteers.
  Sêdek G, Jorga K, Schmitt M, Burns RS, Leese P> ;Clin Neuropharmacol. 1997-12-01
• Evidence-based medicine holds the key to the future for geriatric medicine.
  Burns R, Pahor M, Shorr RI> ;J Am Geriatr Soc. 1997-10-01
• Acute effects of COMT inhibition on L-DOPA pharmacokinetics in patients treated with carbidopa and selegiline.
  Davis TL, Roznoski M, Burns RS> ;Clin Neuropharmacol. 1995-08-01
• Beyond the black box of comprehensive geriatric assessment.
  Burns R> ;J Am Geriatr Soc. 1994-10-01
• 12 citations
  Subclinical damage to the nigrostriatal dopamine system by MPTP as a model of preclinical Parkinson's disease: a review.
  R. S. Burns> ;Acta Neurologica Scandinavica. Supplementum. 1991 Oct 1
• 3 citations
  Alterations in prealbumin concentration after adrenal autotransplantation for Parkinson's disease.
  Steven R. Abram, Johnathan B. Kruskal, George S. Allen, R. Stanley Burns, Robert A. Parker, Noel Tulipan> ;Experimental Neurology. 1990 May 1
• Adrenal medullary tissue transplantation in Parkinson's disease: a review.
  Burns RS, Allen GS, Tulipan NB> ;Adv Neurol. 1990-01-01
• Local cerebral metabolic effects of L-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys.
  Porrino LJ, Burns RS, Crane AM, Palombo E, Kopin IJ, Sokoloff L> ;Proc. Natl. Acad. Sci. U.S.A.. 1987-08-01
• Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the primate.
  Porrino LJ, Burns RS, Crane AM, Palombo E, Kopin IJ, Sokoloff L> ;Life Sci.. 1987-04-27
• Determination and visualization of damage to striatal dopaminergic terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism by [18F]-labeled 6-fl...
  Chiueh CC, Firnau G, Burns RS, Nahmias C, Chirakal R, Kopin IJ, Garnett ES> ;Adv Neurol. 1987-01-01
• Nutritional assessment of community-living well elderly.
  Burns R, Nichols L, Calkins E, Blackwell S, Pragay D> ;J Am Geriatr Soc. 1986-11-01
• 47 citations
  Dystonia in untreated parkinsonism.
  Peter A. LeWitt, R. S. Burns, Richard P. Newman> ;Clinical Neuropharmacology. 1986 Jan 1
• 29 citations
  CSF dopamine‐‐hydroxylase activity in Parkinson's disease
  Jeffrey H. Hurst, P. A. LeWitt, R. S. Burns, Norman L. Foster, Walter Lovenberg> ;Neurology. 1985 Apr 1
• Decreased 6-hydroxymelatonin excretion in Korsakoff's psychosis.
  Martin PR, Higa S, Burns RS, Tamarkin L, Ebert MH, Markey SP> ;Neurology. 1984-07-01
• Difficulties in long term management of Parkinson's disease.
  Burns R> ;Aust Fam Physician. 1984-05-01
• Distribution of free and conjugated dopamine in monkey brain, peripheral tissues and cerebrospinal fluid determined by high-performance liquid chromatography.
  Elchisak MA, Cosgrove SE, Ebert MH, Burns RS> ;Brain Res.. 1983-11-21
• Join now to see all